Dr. Richard T. Silver, Professor of Medicine, Division of Hematology and Medical Oncology, and Emeritus Director of the Richard T. Silver, M.D. Myeloproliferative Neoplasms Center at Weill Cornell Medicine, has received a 2019 ELN Merit Award in recognition of his contributions to international integration of research in the field of leukemia.
Dr. Silver was honored with the 2019 ELN Merit Award at the 16th European LeukemiaNet (ELN) Symposium held in Mannheim, Germany on February 12, 2019. A charitable non-profit organization, the ELN seeks to improve the care of leukemia patients in Europe and globally as well as to reinvigorate the clinical development of new strategies and drugs. At the symposium, Dr. Silver’s achievements were highlighted beginning with his studies in the Brazilian jungle during the 1950s when he discovered a new blood subgroup in the Indian population. This critical discovery led to Dr. Silver becoming a Fellow with the renowned Explorers Club. Throughout his distinguished career, Dr. Silver has remained at the forefront of research and clinical advances for the treatment of leukemia, and by the 1990s, he was appointed Chair of the Chronic Myeloid Leukemia (CML) Guidelines Committee of the American Society of Hematology. In 2004, the European LeukemiaNet recognized Dr. Silver’s “integrative and successful leadership” with an appointment to the ELN’s panel for management and recommendations on CML.
Dr. Rüdiger Hehlmann, Founder and Chair of the European LeukemiaNet, noted that Dr. Silver was responsible for bringing Weill Cornell Medicine into the European LeukemiaNet as its first U.S. institution and regular participant.
The Weill Department of Medicine congratulates Dr. Silver on this prestigious honor.